DiscoveryProbe™ Clinical & FDA
approved Drug Library-DiscoveryProbe™ Clinical & FDA approved Drug Library- ￥33
- APExBIO
- 美国
- APE-L1052-096
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
该DiscoveryProbe™ Clinical & FDA approved Drug Library产品的保存方式具体查看产品。
- 保质期：
1年
- 英文名：
DiscoveryProbe™ Clinical & FDA approved Drug Library
- 库存：
100
- 供应商：
艾美捷科技
- CAS号：
无
- 规格：
100uL/well(10 mM solution),96 Well Deep Well Plate
DiscoveryProbe™ Clinical & FDA approved Drug Library，DiscoveryProbe™ Clinical & FDA approved Drug Library，DiscoveryProbe™ Clinical & FDA approved Drug Library,DiscoveryProbe™ Clinical & FDA approved Drug Library
DiscoveryProbe™ Clinical & FDA approved Drug Library-DiscoveryProbe™ Clinical & FDA approved Drug Library
产品货号：APE-L1052-096
产品规格：100uL/well(10 mM solution),96 Well Deep Well Plate
2726个临床和FDA批准药物小分子的集合，提供冻干粉或DMSO溶液形式
Screening Library
DiscoveryProbe™ Clinical & FDA approved Drug Library-DiscoveryProbe™ Clinical & FDA approved Drug Library该DiscoveryProbe™ Clinical & FDA approved Drug Library产品的保存方式具体查看产品。
点击：DiscoveryProbe™ Clinical & FDA approved Drug Library-DiscoveryProbe™ Clinical & FDA approved Drug Library查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多APExBIO公司特色小分子抑制剂等产品评论，请点击查看艾美捷特色产品中心。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验GPCR Signaling: Understanding the Pathway to Successful Drug Discovery
Modulators of G protein-coupled receptors (GPCRs) form a key area for the pharmaceutical industry, representing ˜27% of all Food and Drug Administration (FDA)-approved drugs. Consequently, there are a wide variety of in vitro plate-based
Sustained-Release Ocular Drug Delivery Systems: Bench to Bedside Development
The process of bringing a drug through early development and on through a successful clinical trials campaign is long and complex. This chapter provides an overview of the drug development process and some of the challenges and pitfalls
Traumatic brain injury is a significant disease affecting 1.4 to 2 million patients every year in the USA. Currently, there are no FDA-approved therapeutic remedies to treat TBI despite the fact that there have been over 200 clinical drug
技术资料暂无技术资料 索取技术资料
